Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yukiko Iwase is active.

Publication


Featured researches published by Yukiko Iwase.


Cancer Letters | 2002

Inhibition of P-glycoprotein by flavonoid derivatives in adriamycin-resistant human myelogenous leukemia (K562/ADM) cells

Tomomi Ikegawa; Hisakazu Ohtani; Noriko Koyabu; Motoharu Ju-ichi; Yukiko Iwase; Chihiro Ito; Hiroshi Furukawa; Mikihiko Naito; Takashi Tsuruo; Yasufumi Sawada

We investigated the effects of natural flavones, quercetin and morin, and their pentamethyl, pentaethyl, pentapropyl, pentabutyl and pentaallyl ethers, on the function of P-glycoprotein (P-gp) assessed by an increase in the uptake of [3H]vincristine by human myelogenous leukemia (K562) cells and adriamycin-resistant human myelogenous leukemia (K562/ADM) cells. Pentamethyl, pentaethyl, pentapropyl and pentaallyl ethers of morin and quercetin (20 microM) all increased the uptake of [3H]vincristine by K562/ADM cells, while quercetin, morin and their pentabutyl ethers had no effect. Pentamethylquercetin, pentaallylquercetin and pentaethylmorin remarkably increased the uptake of [3H]vincristine by K562/ADM cells by 10.6, 10.8 and 14.4-fold, respectively. These inhibitory potencies for P-gp were more potent than typical P-gp inhibitors, cyclosporine A and verapamil. Taking into consideration that these flavonoid derivatives possess antitumor promoter activity, they may become candidates of effective multidrug resistance-reversing agents in cancer chemotherapy.


Cancer Letters | 2001

Inhibitory effect of flavonoid derivatives on Epstein–Barr virus activation and two-stage carcinogenesis of skin tumors

Yukiko Iwase; Yuko Takemura; Motoharu Ju-ichi; Teruo Mukainaka; Eiichiro Ichiishi; Chihiro Ito; Hiroshi Furukawa; Masamichi Yano; Harukuni Tokuda; Hoyoku Nishino

To search for possible anti-tumor promoters, ten flavonoid derivatives (1-10) synthesized from morin and quercetin were examined for their inhibitory effects on the Epstein-Barr virus early antigen (EBV-EA) activation by a short-term in vitro assay. Of these compounds, pentaallyl ethers (9, 10) showed significant inhibitory effects on EBV-EA activation induced by the tumor promoter, 12-O-tetradecanoylphorbol 13-acetate. Further, quercetin pentaallyl ether (10) exhibited remarkable inhibitory effects on mouse skin tumor promotion in an in vivo two-stage carcinogenesis test.


Cancer Letters | 1999

Inhibitory effect of Epstein–Barr virus activation by Citrus fruits, a cancer chemopreventor

Yukiko Iwase; Yuko Takemura; Motoharu Ju-ichi; Satoru Kawaii; Masamichi Yano; Yoko Okuda; Teruo Mukainaka; Atsushi Tsuruta; Masato Okuda; Junko Takayasu; Harukuni Tokuda; Hoyoku Nishino

To search useful compounds in Citrus fruit for cancer chemoprevention, we carried out a primary screening of extracts of fruit peels and seeds from 78 species of the genus Citrus and those from two Fortunella and one Poncirus species, which were closely related to the genus Citrus. These Citrus extracts inhibited the Epstein-Barr virus early antigen (EBV-EA) activation induced by 12-O-tetradecanoylphorbol 13-acetate (TPA) as a useful screening method for anti-tumor promoters. Our results indicated that Citrus containing substances may be inhibit susceptibility factors involved in the events leading to the development of cancer.


Cancer Letters | 2000

Inhibitory effect of flavonoids from Citrus plants on Epstein–Barr virus activation and two-stage carcinogenesis of skin tumors

Yukiko Iwase; Yuko Takemura; Motoharu Ju-ichi; Chihiro Ito; Hiroshi Furukawa; Satoru Kawaii; Masamichi Yano; Xiao Yang Mou; Junko Takayasu; Harukuni Tokuda; Hoyoku Nishino


Cancer Letters | 2001

Cancer chemopreventive activity of 3,5,6,7,8,3', 4'-heptamethoxyflavone from the peel of citrus plants

Yukiko Iwase; Yuko Takemura; Motoharu Ju-ichi; Masamichi Yano; Chihiro Ito; Hiroshi Furukawa; Teruo Mukainaka; Masashi Kuchide; Harukuni Tokuda; Hoyoku Nishino


Chemical & Pharmaceutical Bulletin | 2001

Isolation and Identification of Two New Flavanones and a Chalcone from Citrus kinokuni

Yukiko Iwase; Maki Takahashi; Yuko Takemura; Motoharu Ju-ichi; Chihiro Ito; Hiroshi Furukawa; Masamichi Yano


Heterocycles | 1999

Products from a Novel Reaction of Di- hydropyrazines with Vichinaldiamines

Tadatoshi Yamaguchi; Shigeru Ito; Yukiko Iwase; Kenji Watanabe; Kazunobu Harano


Heterocycles | 2000

A Diamine-Exchange Reaction of Dihydropyrazines

Tadatoshi Yamaguchi; Shigeru Ito; Yukiko Iwase; Kenji Watanabe; Kazunobu Harano


Heterocycles | 2000

A Novel Dimeric Coumarin from Citrus lumia

Motoharu Ju-ichi; Yukiko Iwase; Maki Takahashi; Tamayo Tada; Yuko Takemura; Chihiro Ito; Hiroshi Furukawa; Toshihiro Hashimoto; Shigeru Takaoka; Yoshinori Asakawa; Masamichi Yano


Chemical & Pharmaceutical Bulletin | 1999

Pregnanes and pregnane glycosides from Hoya carnosa

Fumiko Abe; Hitomi Fujishima; Yukiko Iwase; Tatsuo Yamauchi; Kazuhiko Kinjo; Shiryo Yaga

Collaboration


Dive into the Yukiko Iwase's collaboration.

Top Co-Authors

Avatar

Motoharu Ju-ichi

Mukogawa Women's University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yuko Takemura

Mukogawa Women's University

View shared research outputs
Top Co-Authors

Avatar

Masamichi Yano

Mukogawa Women's University

View shared research outputs
Top Co-Authors

Avatar

Harukuni Tokuda

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Hoyoku Nishino

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Maki Takahashi

Mukogawa Women's University

View shared research outputs
Top Co-Authors

Avatar

Teruo Mukainaka

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Junko Takayasu

Kyoto Prefectural University of Medicine

View shared research outputs
Researchain Logo
Decentralizing Knowledge